Clinical Trial Update: 18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer [NA]

View source ↗

Summary

This clinical trial update concerns the PET imaging radiotracer 18F-FAZA for lung cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• 18F-Fluoroazomycin Arabinoside (18F-FAZA) (Fluoroazomycin Arabinoside)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Lung Cancer | NA | Status: ACTIVE_NOT_RECRUITING